US4194047A
(en)
|
1975-11-21 |
1980-03-18 |
Merck & Co., Inc. |
Substituted N-methylene derivatives of thienamycin
|
US4260543A
(en)
|
1978-07-03 |
1981-04-07 |
Merck & Co., Inc. |
Crystalline N-formimidoyl thienamycin
|
US4409214A
(en)
|
1979-11-19 |
1983-10-11 |
Fujisawa Pharmaceutical, Co., Ltd. |
7-Acylamino-3-vinylcephalosporanic acid derivatives and processes for the preparation thereof
|
FR2573070B1
(fr)
|
1984-11-13 |
1987-01-30 |
Rhone Poulenc Sante |
Procede de preparation de composes carbonyles
|
US4783443A
(en)
|
1986-03-03 |
1988-11-08 |
The University Of Chicago |
Amino acyl cephalosporin derivatives
|
CA1283404C
(en)
|
1986-07-01 |
1991-04-23 |
Shigeru Sanai |
Cephalosporin compounds, processes for their preparation and antibacterial agents
|
ZA893284B
(en)
|
1988-05-04 |
1990-03-28 |
Igen Inc |
Peptide analogs and their use as haptens to elicit catalytic antibodies
|
US5442100A
(en)
|
1992-08-14 |
1995-08-15 |
The Procter & Gamble Company |
β-aminoalkyl and β-N-peptidylaminoalkyl boronic acids
|
US5888998A
(en)
|
1997-04-24 |
1999-03-30 |
Synphar Laboratories, Inc. |
2-oxo-1-azetidine sulfonic acid derivatives as potent β-lactamase inhibitors
|
US6184363B1
(en)
|
1997-06-13 |
2001-02-06 |
Northwestern University |
Inhibitors of β-lactamases and uses therefor
|
EP1009415A4
(en)
|
1997-06-13 |
2000-10-25 |
Univ Northwestern |
INHIBITORS OF $ g (b) -LACTAMASES AND THEIR USES
|
WO2000035904A1
(en)
|
1998-12-16 |
2000-06-22 |
Northwestern University |
INHIBITORS OF β-LACTAMASES AND USES THEREFOR
|
WO2000035905A1
(en)
|
1998-12-16 |
2000-06-22 |
Northwestern University |
INHIBITORS OF β-LACTAMASES AND USES THEREFOR
|
BR0014279A
(pt)
|
1999-09-25 |
2002-05-21 |
Smithkline Beecham Plc |
Derivados de piperazina como antagonistas 5-ht1b
|
EP1227722A1
(en)
|
1999-10-28 |
2002-08-07 |
Merck & Co., Inc. |
Novel succinic acid metallo-beta-lactamase inhibitors and their use in treating bacterial infections
|
AU2001292732A1
(en)
|
2000-09-12 |
2002-03-26 |
Larry C. Blasczcak |
Beta-lactam analogs and uses therefor
|
DE60111757T2
(de)
|
2000-09-14 |
2006-04-27 |
Pantherix Ltd. |
3-(Heteroarylacetamido)-2-oxoazetidin-1-sulfonsäure-derivate als antibakterielle Mittel
|
US6586615B1
(en)
|
2001-01-10 |
2003-07-01 |
Bristol-Myers Squibb Company |
α-aminoboronic acids prepared by novel synthetic methods
|
DE10118698A1
(de)
|
2001-04-17 |
2002-11-07 |
Jerini Ag |
Verfahren zur Immobilisierung und damit hergestellte Anordnungen von Verbindungen auf einer planaren Oberfläche
|
FR2835186B1
(fr)
|
2002-01-28 |
2006-10-20 |
Aventis Pharma Sa |
Nouveaux composes heterocycliques, actifs comme inhibiteurs de beta-lactamases
|
JP2003229277A
(ja)
|
2002-02-04 |
2003-08-15 |
Matsushita Electric Ind Co Ltd |
発光素子材料およびそれを用いた発光素子並びに装置
|
AUPS065102A0
(en)
|
2002-02-20 |
2002-03-14 |
Unisearch Limited |
Fluorous acetalation
|
US7176227B2
(en)
|
2002-09-11 |
2007-02-13 |
Kureha Corporation |
Amine compounds and use thereof
|
EP2325226A1
(en)
|
2002-10-30 |
2011-05-25 |
Sumitomo Chemical Company, Limited |
Complex aryl copolymer compounds and polymer light emitting devices made by using the same
|
US7439253B2
(en)
|
2002-12-06 |
2008-10-21 |
Novexel |
Heterocyclic compounds, their preparation and their use as medicaments, in particular as antibacterials and beta-lactamase inhibitors
|
US7271186B1
(en)
|
2002-12-09 |
2007-09-18 |
Northwestern University |
Nanomolar β-lactamase inhibitors
|
JP2006511587A
(ja)
|
2002-12-20 |
2006-04-06 |
ミジェニックス コーポレイション |
アデニンヌクレオチドトランスロカーゼ(ant)リガンドならびにそれに関連する組成物および方法
|
TW200418791A
(en)
|
2003-01-23 |
2004-10-01 |
Bristol Myers Squibb Co |
Pharmaceutical compositions for inhibiting proteasome
|
JP4233365B2
(ja)
|
2003-03-25 |
2009-03-04 |
三井化学株式会社 |
アザジオール錯体化合物、及び該化合物を用いる光記録媒体
|
US7842941B2
(en)
|
2003-10-06 |
2010-11-30 |
Sumitomo Chemical Company, Limited |
Aromatic compound
|
EP1678180B1
(en)
|
2003-10-10 |
2007-08-08 |
Pfizer Products Incorporated |
Substituted 2h-[1,2,4]triazolo 4,3-a pyrazines as gsk-3 inhibitors
|
TW200600494A
(en)
|
2004-03-08 |
2006-01-01 |
Chugai Pharmaceutical Co Ltd |
Bisphenyl compounds useful as vitamin d3 receptor agonists
|
US20060019116A1
(en)
|
2004-07-22 |
2006-01-26 |
Eastman Kodak Company |
White electroluminescent device with anthracene derivative host
|
TW200618820A
(en)
|
2004-11-05 |
2006-06-16 |
Alza Corp |
Liposome formulations of boronic acid compounds
|
US20060178357A1
(en)
|
2005-02-10 |
2006-08-10 |
Buynak John D |
Chphalosporin-derived mercaptans as inhibitors of serine and metallo-beta-lactamases
|
SI3424932T1
(sl)
|
2005-02-16 |
2021-08-31 |
Anacor Pharmaceuticals, Inc. |
Boronoftalidi za terapevtsko uporabo
|
TWI345562B
(en)
|
2005-02-22 |
2011-07-21 |
Teva Pharma |
Rosuvastatin and salts thereof free of rosuvastatin alkylether and a process for the preparation thereof
|
WO2006101779A2
(en)
|
2005-03-15 |
2006-09-28 |
The University Of Chicago |
Non-aqueous electrolytes for lithium ion batteries
|
TW200734311A
(en)
|
2005-11-21 |
2007-09-16 |
Astrazeneca Ab |
New compounds
|
MX338505B
(es)
|
2005-12-07 |
2016-04-20 |
Basilea Pharmaceutica Ag |
Combinaciones utiles de antibioticos de monobactama con inhibidores de beta-lactamasa.
|
PL1988779T3
(pl)
|
2006-02-16 |
2015-10-30 |
Anacor Pharmaceuticals Inc |
Małe cząsteczki zawierające bor jako środki przeciwzapalne
|
AU2007300531A1
(en)
|
2006-09-27 |
2008-04-03 |
Merck Sharp & Dohme Corp. |
Novel inhibitors of beta-lactamase
|
NZ579375A
(en)
|
2007-03-23 |
2012-02-24 |
Basilea Pharmaceutica Ag |
Combination medicaments for treating bacterial infections
|
GB0719366D0
(en)
|
2007-10-03 |
2007-11-14 |
Smithkline Beecham Corp |
Compounds
|
US20100120715A1
(en)
|
2007-11-13 |
2010-05-13 |
Burns Christopher J |
Beta-lactamase inhibitors
|
US20100286092A1
(en)
|
2007-11-13 |
2010-11-11 |
Burns Christopher J |
Beta-lactamase inhibitors
|
DK2666774T3
(en)
|
2008-01-18 |
2015-03-23 |
Merck Sharp & Dohme |
Beta-lactamase INHIBITORS
|
US8129398B2
(en)
|
2008-03-19 |
2012-03-06 |
Bristol-Myers Squibb Company |
HIV integrase inhibitors
|
WO2009140309A2
(en)
|
2008-05-12 |
2009-11-19 |
Anacor Pharmaceuticals, Inc. |
Boron-containing small molecules
|
WO2009139834A1
(en)
|
2008-05-13 |
2009-11-19 |
Poniard Pharmaceuticals, Inc. |
Bioactive compounds for treatment of cancer and neurodegenerative diseases
|
US20120046242A1
(en)
|
2008-12-24 |
2012-02-23 |
Massachusetts Institute Of Technology |
Molecular activators of the wnt/beta-catenin pathway
|
WO2010097675A1
(en)
|
2009-02-27 |
2010-09-02 |
Dhanuka Laboratories Ltd. |
An improved preparation process for cefpodoxime proxetil
|
US20100292185A1
(en)
|
2009-05-12 |
2010-11-18 |
Burns Christopher J |
Beta-lactamase inhibitors
|
JP2012529511A
(ja)
|
2009-06-08 |
2012-11-22 |
アブラクシス バイオサイエンス リミテッド ライアビリティー カンパニー |
トリアジン誘導体類及びそれらの治療応用
|
US8343944B2
(en)
|
2009-07-28 |
2013-01-01 |
Anacor Pharmaceuticals, Inc. |
Trisubstituted boron-containing molecules
|
CA2828114A1
(en)
|
2010-02-26 |
2011-09-01 |
Gary Igor DMITRIENKO |
Cephalosporin derivatives useful as .beta.-lactamase inhibitors and compositions and methods of use thereof
|
MX2012011298A
(es)
|
2010-03-31 |
2012-11-06 |
Millennium Pharm Inc |
Derivados del acido 1-amino-2-ciclopropiletilboronico.
|
US20110288063A1
(en)
|
2010-05-19 |
2011-11-24 |
Naeja Pharmaceutical Inc. |
Novel fused bridged bicyclic heteroaryl substituted 6-alkylidene penems as potent beta-lactamase inhibitors
|
BR112013003045B1
(pt)
*
|
2010-08-10 |
2021-08-31 |
Rempex Pharmaceuticals, Inc. |
Composto e respectivo uso, composição farmacêutica, recipiente estéril e método para preparar composição farmacêutica para administração
|
RS54750B1
(sr)
|
2010-10-26 |
2016-10-31 |
Mars Inc |
Borati kao inhibitori arginaze
|
WO2012067664A1
(en)
|
2010-11-18 |
2012-05-24 |
Glaxo Group Limited |
Compounds
|
EP2487159A1
(en)
|
2011-02-11 |
2012-08-15 |
MSD Oss B.V. |
RorgammaT inhibitors
|
EP2508506A1
(en)
|
2011-04-08 |
2012-10-10 |
LEK Pharmaceuticals d.d. |
Preparation of sitagliptin intermediates
|
US9012491B2
(en)
|
2011-08-31 |
2015-04-21 |
Rempex Pharmaceuticals, Inc. |
Heterocyclic boronic acid ester derivatives and therapeutic uses thereof
|
WO2013053372A1
(en)
|
2011-10-13 |
2013-04-18 |
Therabor Pharmaceuticals |
Boronic acid inhibitors of beta-lactamases
|
WO2013056163A1
(en)
|
2011-10-14 |
2013-04-18 |
The Regents Of The University Of California |
Beta-lactamase inhibitors
|
MX352652B
(es)
|
2011-12-22 |
2017-12-04 |
Ares Trading Sa |
Inhibidores de inmunoproteasoma selectivos de derivados del acido alfa-amino boronico.
|
US20150018311A1
(en)
|
2012-01-09 |
2015-01-15 |
University of Tromsø |
Therapeutic boron-containing compounds
|
EP2615080A1
(en)
|
2012-01-12 |
2013-07-17 |
LEK Pharmaceuticals d.d. |
Preparation of Optically Pure ß-Amino Acid Type Active Pharmaceutical Ingredients and Intermediates thereof
|
WO2013122888A2
(en)
*
|
2012-02-15 |
2013-08-22 |
Rempex Pharmaceuticals, Inc. |
Methods of treating bacterial infections
|
US9156858B2
(en)
|
2012-05-23 |
2015-10-13 |
Rempex Pharmaceuticals, Inc. |
Boronic acid derivatives and therapeutic uses thereof
|
US10561675B2
(en)
|
2012-06-06 |
2020-02-18 |
Rempex Pharmaceuticals, Inc. |
Cyclic boronic acid ester derivatives and therapeutic uses thereof
|
US9422314B2
(en)
|
2012-12-07 |
2016-08-23 |
VenatoRx Pharmaceuticals, Inc. |
Beta-lactamase inhibitors
|
CN104994844A
(zh)
|
2013-01-04 |
2015-10-21 |
莱姆派克斯制药公司 |
硼酸衍生物及其治疗用途
|
US9241947B2
(en)
|
2013-01-04 |
2016-01-26 |
Rempex Pharmaceuticals, Inc. |
Boronic acid derivatives and therapeutic uses thereof
|
US9132140B2
(en)
|
2013-01-04 |
2015-09-15 |
Rempex Pharmaceuticals, Inc. |
Boronic acid derivatives and therapeutic uses thereof
|
US9101638B2
(en)
|
2013-01-04 |
2015-08-11 |
Rempex Pharmaceuticals, Inc. |
Boronic acid derivatives and therapeutic uses thereof
|
US8999885B2
(en)
|
2013-01-09 |
2015-04-07 |
General Electric Company |
Methods of activating charcoal resulting from biomass gasification
|
ES2730013T3
(es)
|
2013-01-10 |
2019-11-07 |
Venatorx Pharmaceuticals Inc |
Inhibidores de betalactamasa
|
WO2014151958A1
(en)
|
2013-03-14 |
2014-09-25 |
VenatoRx Pharmaceuticals, Inc. |
Beta-lactamase inhibitors
|
EP3139930A4
(en)
|
2014-05-05 |
2018-01-17 |
Rempex Pharmaceuticals, Inc. |
Salts and polymorphs of cyclic boronic acid ester derivatives and therapeutic uses thereof
|
CA2947041A1
(en)
|
2014-05-19 |
2015-11-26 |
Rempex Pharmaceuticals, Inc. |
Boronic acid derivatives and therapeutic uses thereof
|
US9511142B2
(en)
|
2014-06-11 |
2016-12-06 |
VenatoRx Pharmaceuticals, Inc. |
Beta-lactamase inhibitors
|
CA2952968A1
(en)
|
2014-07-01 |
2016-01-07 |
Rempex Pharmaceuticals, Inc. |
Boronic acid derivatives and therapeutic uses thereof
|
WO2016065282A1
(en)
|
2014-10-24 |
2016-04-28 |
The Regents Of The University Of Michigan |
Nasal formulation, nasal kit, and method for enhancing nasal nitric oxide (no) levels
|
WO2016172208A1
(en)
|
2015-04-24 |
2016-10-27 |
Rempex Pharmaceuticals, Inc. |
Methods of treating bacterial infections
|